• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARDINAL HEALTH SANTA CLARA MYNX CONTROL; DEVICE, HEMOSTASIS, VASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARDINAL HEALTH SANTA CLARA MYNX CONTROL; DEVICE, HEMOSTASIS, VASCULAR Back to Search Results
Catalog Number MX6760E
Device Problems Premature Activation (1484); Decrease in Pressure (1490); Material Rupture (1546)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/19/2024
Event Type  malfunction  
Manufacturer Narrative
This device is available for analysis, but the engineering report is not yet available.However, it will be submitted within 30 days upon receipt.Additional information is pending and will be submitted within 30 days upon receipt.
 
Event Description
As reported, the balloon of a 6/7f mynx control vascular closure device (vcd) ruptured during the maneuver of pulling the balloon through the calcified vessel.Subsequently, the procedure was successfully completed using another mynx control vcd.There was no reported patient injury.The device had been stored and prepared in accordance with the instructions for use (ifu).The balloon lost pressure slightly after being pulled to the arteriotomy.However, before losing pressure fully, the operator was able to check the leakage from the balloon in the angiography.Upon confirming the leakage, the device was promptly removed without utilizing the buttons.The femoral artery¿s suitability was verified on angiography or venography including the insertion angle (30-45 degrees) of the 6f non-cordis vascular sheath introducer.The vessel diameter was confirmed to be equal to or greater than 5 mm.There was moderate vessel tortuosity.There was severe presence of calcium in the vicinity of the puncture site.There was no prior pta, stent, or vascular graft in the common femoral artery.The procedure involved an interventional peripheral procedure with a retrograde approach.The operator held certification for using the mynx device.Other procedural details were requested but are unknown, unavailable, not answered, or not applicable.The device will be returned for evaluation.Addendum: based on preliminary review of the returned device received for decontamination, the sealant was exposed to blood and exposed from the sealant sleeves.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MYNX CONTROL
Type of Device
DEVICE, HEMOSTASIS, VASCULAR
Manufacturer (Section D)
CARDINAL HEALTH SANTA CLARA
5452 betsy ross drive
santa clara CA 95054
Manufacturer (Section G)
CORDIS US CORP.
14201 nw 60 avenue
miami lakes FL 33014
Manufacturer Contact
karla castro
5452 betsy ross drive
santa clara, CA 95054
7863138372
MDR Report Key19118155
MDR Text Key340695335
Report Number3004939290-2024-00188
Device Sequence Number1
Product Code MGB
Combination Product (y/n)N
Reporter Country CodeKS
PMA/PMN Number
P040044
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 04/16/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/16/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberMX6760E
Device Lot NumberF2400505
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/01/2024
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received03/25/2024
Date Device Manufactured02/01/2024
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
6F TERUMO RADIFOCUS INTRODUCER 2 SHEATH; ANOTHER UNKNOWN MYNX CONTROL
Patient EthnicityNon Hispanic
Patient RaceAsian
-
-